Global Platelet Rich Plasma (PRP) Market Growth 2023-2029

Global Platelet Rich Plasma (PRP) Market Growth 2023-2029

Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play a biological role in the healing process and are provided at concentrated levels in PRP. Thus, PRP may help optimize the conditions for healing of bone and soft tissue.
LPI (LP Information)' newest research report, the “Platelet Rich Plasma (PRP) Industry Forecast” looks at past sales and reviews total world Platelet Rich Plasma (PRP) sales in 2022, providing a comprehensive analysis by region and market sector of projected Platelet Rich Plasma (PRP) sales for 2023 through 2029. With Platelet Rich Plasma (PRP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Platelet Rich Plasma (PRP) industry.
This Insight Report provides a comprehensive analysis of the global Platelet Rich Plasma (PRP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Platelet Rich Plasma (PRP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Platelet Rich Plasma (PRP) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Platelet Rich Plasma (PRP) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Platelet Rich Plasma (PRP).
The global Platelet Rich Plasma (PRP) market size is projected to grow from US$ 288.6 million in 2022 to US$ 622.9 million in 2029; it is expected to grow at a CAGR of 622.9 from 2023 to 2029.
Global Platelet Rich Plasma key players include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, etc. Global top four manufacturers hold a share about 75%.
North America is the largest market, with a share about 55%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, P-PRP is the largest segment, with a share over 60%. And in terms of application, the largest application is Orthopedic Surgery, followed by Cosmetic Surgery, General Surgery, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Platelet Rich Plasma (PRP) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
P-PRP
L-PRP
L-PRF
Segmentation by application
Orthopedic Surgery
Cosmetic Surgery
General Surgery
Other Surgeries
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Exactech
Emcyte Corporation
Arteriocyte
Adilyfe
Key Questions Addressed in this Report
What is the 10-year outlook for the global Platelet Rich Plasma (PRP) market?
What factors are driving Platelet Rich Plasma (PRP) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Platelet Rich Plasma (PRP) market opportunities vary by end market size?
How does Platelet Rich Plasma (PRP) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.